MAPT and Alzheimer disease: Strikingly, an increase in the mitochondrial DNA/nuclear DNA ratio, as well as in mitophagy markers (COX IV and TOMM20), were observed in the brain of tau-positive AD patients, compared to tau-negative patients and healthy controls [133].